期刊文献+

乙型脑炎减毒活疫苗皮下感染入脑试验半定量检测法的方法学验证 被引量:1

Validation of semi-quantitative determination method for neurotropism test on live attenuated Japanese encephalitis vaccine for subcutaneous injection in mice
原文传递
导出
摘要 目的采用半定量法对乙型脑炎减毒活疫苗皮下感染入脑动物试验进行方法学验证。方法引入逐日观察打分的方法,将皮下感染入脑试验由定性转变为半定量动物试验,验证该方法的精密度(重复性)、中间精密度、准确度、特异性。结果皮下感染入脑试验半定量检测方法具有良好的精确度(重复性),中间精密度及特异性。各项验证参数均达到预先设定的可接受标准。结论该方法与用途一致,且与供试品相适宜,可用于乙型脑炎减毒活疫苗的质量控制。 Objective To validate the neurotropism test on live attenuated Japanese encephalitis(JE) inoculated for subcutaneous injection by semi-quantitative method.Methods The neurotropism test on JE vaccine for s.c.injection was changed into semi-quantitative test by introducing score method,and verified for precision(reproducibility),intermedia precision,accuracy and specificity.Results The semi-quantitative method for neurotropism test showed high precision(reproducibility),intermedia precision,accuracy and specificity,of which all the validation parameters reached the acceptable criteria designed.Conclusion Validation result showed that the semi-quantitative method was appropriate for its intended use and suitable for the test samples,which might be used for the quality control of live attenuated JE vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第9期1216-1219,共4页 Chinese Journal of Biologicals
基金 国家科技支撑计划(2008BAI66B05)
关键词 乙型脑炎减毒活疫苗 皮下感染 入脑试验 验证 半定量法 Live attenuated Japanese encephalitis vaccine Subcutaneous infection Neurotropism test Validation Semi-quantitative method
  • 相关文献

参考文献12

  • 1中华人民共和国卫生部.药品生产质量管理规范及附录[S].2011-01-17.
  • 2World Health Organization.Annex 3.WHO good manufacturingpractices:main principles for pharmaceutical products[R].WHOTechnical Report Series,2011,961:94-147.
  • 3World Health Organization.Annex 2.WHO good practices for ac-tive pharmaceutical ingredients,section 12.8:validation of ana-lytical methods[R].WHO Technical Report Series,2010,957:167.
  • 4World Health Organization.Annex 4.Supplementary guidelines ongood manufacturing practices:validation;Appendix 4 Analyticalmethod validation[R].WHO Technical Report Series,2006,937:148-152.
  • 5World Health Organization.Annex 1.WHO good practices forpharmaceutical quality control laboratories(GLP)[R].WHO Tech-nical Report Series,2010,957:81-129.
  • 6World Health Organization.Manual of laboratory methods for test-ing vaccines used in the WHO expanded programme on immuniza-tion,partⅠgeneral,section 1.5,selection and implementation ofmethods;section 1.6,validation of methods,WHO/VSQ/97.04[EB/OL].1997:7-8.
  • 7The United States Pharmacopeial Convention.<1226>,Verificationof compendia procedure,Usp32-NF27,pharmacopeial forum:vol-ume No.32(4)[M].2009:1232.
  • 8The United States Pharmacopeial Convention.<1225>,Validationof compendia procedure,Usp32-NF27,pharmacopeial forum:vol-ume No.34(3)[M].2009:794.
  • 9World Health Organization.Supplementary guidelines on goodmanufacturing practices(GMP):Validation;Annex 4,Analyticalmethod validation.Working document QAS/0.055/Rev.2[EB/OL].2005:33-37.
  • 10World Health Organization.A WHO guide to good manufacturepractice(GMP)requirements,part 2:validation;section 15,valida-tion of analytical method,WHO/VSQ/97.02[M].1997:69-73.

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部